VentureWell
Through the Blueprint MedTech Incubator Hubs Program, VentureWell provides commercialization support to Stanford University scientists who are developing an artificial retina.
In recent focus groups, faculty and administrators from HBCUs and Emerging Research Institutions shared their perspective on current challenges.
VentureWell’s Chelsea Schiller reflects on a period of advancing commercialization readiness, leveraging network expertise, and convening network members.
The field of women’s health has evolved rapidly, coalescing into a powerful new movement. VentureWell’s unique capabilities help ensure that every dollar directed toward women’s health can make an outsized impact.
Podcasts shaping how we think about the future of science and technology innovation and entrepreneurship.
VentureWell alumni offer advice to healthtech innovators.
Explore key findings from the Investor Catalyst Hub’s network survey.
The ARPA-H Investor Catalyst Hub connected Belle.ai to spokes within its network that could help it validate its customer segments.
ReBlood Rx, founded by Carlos Munoz and Christopher Caballero, has developed a revolutionary hemoglobin-based oxygen delivery system—essentially a blood alternative.
As the Commercialization Center, VentureWell provided infrastructure support for a life-saving hepatitis C test-to-treat breakthrough.
LymeAlert created a kit to help people identify whether a tick carries Lyme-causing bacteria—right at home.
Bias in STEM impedes technology commercialization path for women faculty.
First Name
Last Name
Your email
Yes I would like receive weekly newsletters from VentureWell
I'd best describe myself as a: StudentStartupFaculty MemberResearcherOther
By continuing to use the site, you agree to the use of cookies. Read MoreAccept